Name: Name:3-Bromo-5-morpholinopyridine
Brand: AABLOCKS
SKU: AA002CFO
Rating: 90 (10 reviews)

Technical Information

Catalog Number: AA002CFO

Chemical Name: 3-Bromo-5-morpholinopyridine

CAS Number: 200064-13-7

Molecular Formula: C9H11BrN2O

Molecular Weight: 243.1004

MDL Number: MFCD11656285

SMILES: Brc1cncc(c1)N1CCOCC1

Properties

Form: Solid

Storage: Keep in dry area;2-8℃;

Complexity: 162

Covalently-Bonded Unit Count: 1

Defined Atom Stereocenter Count: 0

Defined Bond Stereocenter Count: 0

Formal Charge: 0

Heavy Atom Count: 13

Hydrogen Bond Acceptor Count: 3

Hydrogen Bond Donor Count: 0

Isotope Atom Count: 0

Rotatable Bond Count: 1

Undefined Atom Stereocenter Count: 0

Undefined Bond Stereocenter Count: 0

XLogP3: 1.3

Downstream Synthesis Route

110-91-8

625-92-3

200064-13-7

4-(3-Bromo-pyridin-4-yl)-morpholine

3,5-di-(4-morpholyl)pyridine

[1]Vinter-Pasquier,Karine;Jamart-Gregoire,Brigitte;Caubere,Paul[Heterocycles,1997,vol.45,#11,p.2113-2129]

110-91-8

200064-13-7

3,5-di-(4-morpholyl)pyridine

[1]Vinter-Pasquier,Karine;Jamart-Gregoire,Brigitte;Caubere,Paul[Heterocycles,1997,vol.45,#11,p.2113-2129]

200064-13-7

1066-54-2

926009-41-8

[1]Matulenko,MarkA.;Paight,ErnestS.;Frey,RobinR.;Gomtsyan,Arthur;DiDomenicoJr.,Stanley;Jiang,Meiqun;Lee,Chih-Hung;Stewart,AndrewO.;Yu,Haixia;Kohlhaas,KathyL.;Alexander,KarenM.;McGaraughty,Steve;Mikusa,Joseph;Marsh,KennanC.;Muchmore,StevenW.;Jakob,ClarissaL.;Kowaluk,ElizabethA.;Jarvis,MichaelF.;Bhagwat,ShripadS.[BioorganicandMedicinalChemistry,2007,vol.15,#4,p.1586-1605]

110-91-8

625-92-3

200064-13-7

[1]Locationinpatent:experimentalpartBunnelle,WilliamH.;Tietje,KarinR.;Frost,JenniferM.;Peters,Dan;Ji,Anguo;Li,Tao;Scanio,MarcJ.C.;Shi,Lei;Anderson,DavidJ.;Dyhring,Tino;Grønlien,JensH.;Ween,Hilde;Thorin-Hagene,Kirsten;Meyer,MichaelD.[JournalofMedicinalChemistry,2009,vol.52,#14,p.4126-4141]

[2]CurrentPatentAssignee:BIOSPLICETHERAPEUTICSINC-US2013/267495,2013,A1Locationinpatent:Paragraph0438-0439

[3]Locationinpatent:experimentalpartDandu,ReddeppaReddy;Rose,AdamC.;Hudkins,RobertL.[Heterocycles,2011,vol.83,#4,p.875-881]

[4]Matulenko,MarkA.;Paight,ErnestS.;Frey,RobinR.;Gomtsyan,Arthur;DiDomenicoJr.,Stanley;Jiang,Meiqun;Lee,Chih-Hung;Stewart,AndrewO.;Yu,Haixia;Kohlhaas,KathyL.;Alexander,KarenM.;McGaraughty,Steve;Mikusa,Joseph;Marsh,KennanC.;Muchmore,StevenW.;Jakob,ClarissaL.;Kowaluk,ElizabethA.;Jarvis,MichaelF.;Bhagwat,ShripadS.[BioorganicandMedicinalChemistry,2007,vol.15,#4,p.1586-1605]

[5]CurrentPatentAssignee:HIBERCELLINC-WO2019/126730,2019,A1Locationinpatent:Paragraph0460

[6]Daili,Farah;Sengmany,Stéphane;Léonel,Eric[EuropeanJournalofOrganicChemistry,2021,vol.2021,#17,p.2462-2469]

[7]CurrentPatentAssignee:EPIZYME,INC.-WO2014/100716,2014,A1Locationinpatent:Paragraph00230

[8]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2011/75559,2011,A1Locationinpatent:Page/Pagecolumn61;62

[9]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-US2014/323468,2014,A1Locationinpatent:Paragraph0542

200064-13-7

926009-42-9

[1]Matulenko,MarkA.;Paight,ErnestS.;Frey,RobinR.;Gomtsyan,Arthur;DiDomenicoJr.,Stanley;Jiang,Meiqun;Lee,Chih-Hung;Stewart,AndrewO.;Yu,Haixia;Kohlhaas,KathyL.;Alexander,KarenM.;McGaraughty,Steve;Mikusa,Joseph;Marsh,KennanC.;Muchmore,StevenW.;Jakob,ClarissaL.;Kowaluk,ElizabethA.;Jarvis,MichaelF.;Bhagwat,ShripadS.[BioorganicandMedicinalChemistry,2007,vol.15,#4,p.1586-1605]

200064-13-7 | 3-Bromo-5-morpholinopyridine